south africa: finger-pointing as state runs out of aids drugs

CDC HIV/AIDS/Viral Hepatitis/STD/TB Prevention News Update SOUTH AFRICA: Finger-Pointing as State Runs Out of AIDS Drugs Tamar Kahn
March 30, 2012

Business Day (Johannesburg) (03.30.12) - Friday, March 30, Basic stocks of an essential HIV/AIDS drug are running dangerously low at health care facilities in Gauteng, Mpumalanga, and North West, putting patients at risk for drug resistance, the Southern African HIV Clinicians Society is warning. The shortage of tenofovir comes amid concerns about the Department of Health's supply-chain management. Public health facilities frequently run out of basic medical supplies, including antibiotics. However, no group has taken responsibility for the problem. The health department's deputy director-general for health regulation and compliance, Anban Pillay, blames pharmaceutical companies for failing to meet demand, and drugmakers say provincial health departments are not ordering correctly or in a timely manner. Several provinces ran out of money for AIDS drugs in 2009, prompting the government to secure US funding for a two-year grant for treatment efforts. That tender was split between Aspen Pharmacare and Sonke Pharmaceuticals. "They are not supplying anything close to what they promised," said Pillay. "Somehow they thought the figures we gave them were inflated. They have told us they are not able to cope with demand." Both companies dispute this. "We have met the upsurge. The issued is demand management," said Stavros Nicolaou, head of Aspen's strategic trade development. "It takes three months to increase production," said Sonke CEO Sotse Segoneco. "They did not order for 10 or 11 months, and now they are flooding us with orders." Despite outstanding debts in Gauteng, both companies noted they continue to supply the province.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Photographs from A Day with HIV Now Online Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 CANADA: Health Officials in St. John's N.L., Inform 50 People of Tuberculosis Risk OHIO: Cleveland LGBT Community Center Offers Free Support Groups and HIV, STD Testing: The Frugal Patient CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland NEVADA: Clinics Offer Low-Cost Care for those Lacking Insurance CONNECTICUT: At Hartford Public High School, A Day Reserved for 'Healthy Relationships' ITALY: HIV Is No Barrier to Successful Liver Transplant for Cancer Treatment KENYA: Kenya Launches Universal HPV Vaccine Access to Youths UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: HIV Vaccine Trials to Start in July Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial) CALIFORNIA: Local Church Sends HIV/AIDS Care Packs to Swaziland UNITED STATES: Navajo Confront an Increase in New H.I.V. Infections Uganda: Remembering Those Killed By HIV/AIDS (International AIDS Candlelight Memorial)Investigators at National Autonomous University Detail Findings in AIDS Education and Prevention 26th Annual Minnesota AIDS Walk - Sunday, May 19, Minnehaha Park AIDS science at 30: 'Cure' now part of lexicon ARIZONA: Parsons Foundation Gives $3 Million to Southwest Center for HIV/AIDS UNITED STATES: Triple Therapy for Hepatitis C is Effective After Liver Transplantation, but Side-Effects Are Common NEW HAMPSHIRE: State Health Officials Urge Hepatitis Testing UNITED STATES: Hepatitis C Testing for People Born Between 1945 and 1965
Copyright © 2012 -CDC Prevention News Update, Publisher. All rights reserved to Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles. Information in this article was accurate in March 30, 2012. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.